EUVIMEDScopri EUVIMED
Systematische ÜbersichtMetaanalyse

Effects of phytosterols on cardiovascular risk factors: A systematic review and meta‐analysis of randomized controlled trials

Yanhong Yang, Jiayue Xia, Tingqing Yu, Shiyun Wan, Yajie Zhou, Guiju Sun iD

Phytotherapy Research · 2025-01 · 39 (1) · 3-24

DOI: 10.1002/ptr.8308 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, published online on 2024-11-21. Written by Yanhong Yang and 5 co-authors. Institution: Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, People's R…. Major MEDLINE topics: Phytosterols, Cardiovascular Diseases. Cited 11 times so far (Crossref); 169 references. Funded by: Nutrition for All Scientific Research Fund Program of the Chinese Nutrition Society.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cardiovascular diseases are the major cause of death globally. The primary risk factors are high blood lipid levels, hypertension, diabetes, and obesity. Phytosterols are naturally occurring plant bioactive substances. Short‐term clinical trials have demonstrated phytosterols' cholesterol‐lowering potential, but their effects on cardiovascular risk factors remain controversial, and relevant meta‐analyses are limited and incomplete. We conducted a systematic and comprehensive search of PubMed, Web of Science, Embase and Cochrane Library up to December 22, 2023. A total of 109 randomized controlled trials (RCTS) of phytosterols (PS) intervention on cardiovascular risk factor outcomes were included in a preliminary screening of the retrieved literature by Endnote 20. We assessed the quality of all included randomized controlled trials using the Cochrane Collaboration's Risk of Bias tool. Cochrane data conversion tool was used for data conversion, and finally Stata was used for meta‐analysis, egger test and sensitivity analysis of the included studies. The results indicated that dietary phytosterols intake could significantly decrease total cholesterol (TC) level (mean difference = −13.41; 95% confidence interval [CI]: −15.19, −11.63, p < 0.001), low density lipoprotein cholesterol (LDL‐C) level (mean difference = −12.57; 95% CI: −13.87, −11.26, p < 0.001), triglycerides (TG) level (mean difference = −6.34; 95% CI: −9.43, −3.25, p < 0.001), C‐reactive protein (CRP) level (mean difference = −0.05; 95% CI: −0.08, −0.01, p = 0.671), systolic blood pressure (SBP) level (mean difference = −2.10; 95% CI: −3.27, −0.9, p < 0.001), diastolic blood pressure (DBP) level (mean difference = −0.83; 95% CI: −0.58, −0.07, p = 0.032), increased high‐density lipoprotein cholesterol (HDL‐C) level (mean difference = 0.46; 95% CI: 0.13, 0.78, p = 0.005), but did not alter the levels of blood glucose (GLU) (mean difference = −0.44; 95% CI: −1.64, 0.76, p = 0.471), glycosylated hemoglobin, Type A1C (HbA1c) (mean difference = −0.28; 95% CI: −0.75, 0.20, p = 0.251), interleukin‐6 (IL‐6) (mean difference = 0.00; 95% CI: −0.02, 0.02, p = 0.980), tumor necrosis factor (TNF‐α) (mean difference = 0.08; 95% CI: −0.08, 0.24, p = 0.335), oxidized low‐density lipoprotein cholesterol (OXLDL‐C) (standard mean difference = 0.16; 95% CI: −0.38, 0.06, p = 0.154), body mass index (BMI) (mean difference = 0.01; 95% CI: −0.07, 0.09, p = 0.886), waist circumference (WC) (mean difference = −0.10; 95% CI: −0.50, 0.30, p = 0.625) and body weight (mean difference = 0.03; 95% CI: −0.18, 0.24, p = 0.787). Our results suggest that phytosterols may be beneficial in reducing the levels of TC, LDL‐C, TG, CRP, SBP, and DBP, but have no significant effect on GLU, HbA1c, TNF‐α, IL‐6, OXLDL‐C, BMI, WC, and Weight. However, there were a small number of RCTS included in this study and their small population size may have reduced the quality of the study. And most of the included studies were short‐term intervention trials. Therefore, higher quality studies need to be designed in future studies to establish more accurate conclusions.

Subjects

MeSH terms (MEDLINE)

PhytosterolsCardiovascular DiseasesHumansRandomized Controlled Trials as TopicHeart Disease Risk FactorsCholesterolCholesterol, LDLC-Reactive ProteinTriglycerides

Author keywords

cardiovascular risk factorsmeta‐analysisphytosterolsrandomized controlled trials

Substances

PhytosterolsCholesterolCholesterol, LDLC-Reactive ProteinTriglycerides

Authors and institutions

  • Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, People's Republic of China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, People's Republic of China.
  • Nanjing Zhongke Pharmaceutical Co. Ltd, Nanjing, People's Republic of China.

ORCID profiles: Guiju Sun

Funding

  • Nutrition for All Scientific Research Fund Program of the Chinese Nutrition Society

Cite

APA

Yang, Y., Xia, J., Yu, T., Wan, S., Zhou, Y., & Sun, G. (2025). Effects of phytosterols on cardiovascular risk factors: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research, 39(1), 3-24. https://doi.org/10.1002/ptr.8308

Vancouver

Yang Y, Xia J, Yu T, Wan S, Zhou Y, Sun G. Effects of phytosterols on cardiovascular risk factors: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2025;39(1):3-24. doi:10.1002/ptr.8308

BibTeX
@article{Yang2025,
  author = {Yang, Yanhong and Xia, Jiayue and Yu, Tingqing and Wan, Shiyun and Zhou, Yajie and Sun, Guiju},
  title = {Effects of phytosterols on cardiovascular risk factors: A systematic review and meta‐analysis of randomized controlled trials},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {1},
  pages = {3--24},
  doi = {10.1002/ptr.8308}
}
Start for free →